Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer.
Liotta
Margaret
M
The Cleveland Clinic, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, 9500 Euclid Ave, A-81, Cleveland, OH 441195, USA.
Rose
Peter G
PG
Escobar
Pedro F
PF
D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced*; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000098:blood supply / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab